Metformin for treatment of antipsychotic-induced weight gain: A randomized, placebo-controlled study
Published Jun 1, 2012 · Man Wang, Jian-hua Tong, G. Zhu
Schizophrenia Research
81
Citations
5
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayMetformin effectively and safely reduces antipsychotic-induced weight gain and insulin resistance in first-episode schizophrenia patients, with good adherence.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.